Journals / Selçuk Tıp Dergisi / 2021 / Cilt: 37 - Sayı: 2

10-Year Endometrium Cancer Management in Our Clinic

Kliniğimizde 10 Yıllık Endometrium Kanser Yönetimi

Pages
[166]–171
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Tumor size, depth of myometrial invasion and histopathologic grade are used to evaluate the risk of the disease, but studies with a higher number of high stage patients will be more useful in determining the risk.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Endometrial cancer is the most common malignancy of the female genital tract and the fourth leading cancer among women.
📊
Key Findings & Data:Patients and Methods: In this study, the records of 164 endometrial cancer patients operated by the same surgical team between 2009-2019 were reviewed retrospectively.
💡
Conclusion & Impact:Tumor size, depth of myometrial invasion and histopathologic grade are used to evaluate the risk of the disease, but studies with a higher number of high stage patients will be more useful in determining the risk.
🔬Design:Review & Systematic Survey
📍Scope:2009-2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Endometrial cancer is the most common malignancy of the female genital tract and the fourth leading cancer among women. Our aim is to share the surgical treatment and results of endometrial cancer cases in our gynecological oncology clinic. Patients and Methods: In this study, the records of 164 endometrial cancer patients operated by the same surgical team between 2009-2019 were reviewed retrospectively. The clinical, surgical and histopathological features of the patients are presented here. Four patients who had sarcoma as a result of pathology, 7 patients who underwent complementary surgery and 1 patient with a second primary tumor were not included in the study . Results: The mean age of the patients included in our study was 61.3 and the mean body mass index was 25.8. According to the postoperative pathology results; mean tumor size was 3.4 cm and mean number of collected lymph nodes was 28.8. Lymph node metastasis was observed in 19 patients and all of the metastases were in pelvic lymph nodes. Endometrioid type adenocarcinoma was seen in 81% of the patients. Myometrial invasion > 50% in 81 patients (49.4%). Twenty patients (12.2%) had cervical involvement, 11 patients (6.7%) had adnexal involvement and 28 patients (17.1%) had lymphovascular area invasion. 76 patients (46.3%) were grade 1, 61 patients (37.2%) were grade 2, 19 patients (11.6%) were grade 3. When the patients were staging according to the FIGO system in 2009, 70 (42.7%) stage 1A, 58 (35.4%) stage 1B, 12 (7.3%) stage 2, 3 (1.8%) stage 3A 17 patients (10.4%) were stage 3C1 and 4 patients (2.4%) were stage 4. Conclusion: Endometrial cancer is the most common gynecological cancer, and it is usually diagnosed at an early stage as a result of early signs. Tumor size, depth of myometrial invasion and histopathologic grade are used to evaluate the risk of the disease, but studies with a higher number of high stage patients will be more useful in determining the risk.

Özet

Endometriyum kanseri kadın genital sisteminin en sık malignitesi olup, kadınlarda görülen kanserler arasında dördüncü sırada yer almaktadır. Amacımız jinekolojik onkoloji kliniğimizdeki endometriyum kanserli olgularının cerrahi tedavi ve sonuçlarını paylaşmaktır . Hastalar ve Yöntem: Bu çalışmada 2009-2019 yılları arasında kliniğimizde endometrium kanseri tanısı alıp aynı cerrahi ekip tarafından opere edilen 164 hastanın dosyaları retrospektif olarak incelenip, hastaların klinik, cerrahi ve histopatolojik özellikleri ile ilgili sonuçlar paylaşılmıştır. Patoloji sonucu sarkom gelen 4 hasta, tamamlayıcı cerrahi yapılan 7 hasta, ikinci bir primer tümörü olan 1 hasta çalışmaya dahil edilmemiştir. Bulgular: Çalışmamıza dahil edilen hastaların ortalama yaşı 61,3 ortalama vücut kitle indeksleri 25,8 idi. Hastaların postoperatif patoloji sonuçlarına göre; ortalama tümör büyüklüğü 3,4 cm, toplanan ortalama lenf nodu sayısı 28,8 idi. 19 hastada lenf nodu metastazı izlendi ve metastazların hepsi pelvik lenf nodlarında idi. Hastaların % 81’inde endometrioid tip adenokarsinom olduğu görüldü. 81 hastada (%49,4) myometrial invazyon > % 50 idi. 20 hastada (%12.2) servikal tutulum, 11 hastada (%6,7) adneksiyal tutulum, 28 hastada (%17,1) lenfovaskuler alan invazyonu mevcuttu. 76 hasta (%46,3) grade 1, 61 hasta (%37,2) grade 2, 19 hasta (%11,6) grade 3’ idi. Hastaların 2009 FIGO sistemine göre evlemesi yapıldığında 70 hasta (%42,7) evre 1A, 58 hasta (%35,4) evre 1B, 12 hasta (%7,3) evre 2, 3 hasta (%1,8) evre 3A, 17 hasta (%10,4) evre 3C1, 4 hasta (%2,4) evre 4 idi. Sonuç: Endometrium kanseri en sık görülen jinekolojik kanser olup, erken dönemde bulgu vermesi sonucu genellikle erken evrede yakalanmaktadır. Hastalığın riskini değerlendirmede tümör boyutu, miyometrial invazyon derinliği, histopatolojik grade kullanılmaktadır ancak özellikle yüksek evre hasta sayının daha fazla olduğu çalışmalar , risk belirlemede daha faydalı olacaktır .

🔖

Cite This Article

DEMİR, E. T., ACAR, A. (2021). 10-Year Endometrium Cancer Management in Our Clinic. Selçuk Tıp Dergisi, Cilt: 37 - Sayı: 2, [166]–171. https://ajindex.com/articles/397197

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics. Cancer J Clin 2019;69(1):7-34. https://hsgm.saglik.gov.tr/tr/kanser-istatistikleri Cancer facts and figures. American Cancer Society, Atlanta, Georgia 2019 [https://www.cancer.org/content/dam/cancerorg/ research/cancer-facts-and-statistics/annual-cancerfacts- and-figures/2019/cancer-facts-and-figures-2019.pdf] Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006;95 Suppl 1:S105-43. Lee NK, Cheung MK, Shin JY, et al. Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol 2007;109(3):655-62.
  2. Karlsson B, Granberg S, Wikland M, et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding-a nordic multicenter study. Am J Obstet Gynecol 1995;172:1488-94.
  3. Siegel RL, Miller KD, Jemal A. Cancer statistics. Cancer J Clin 2015;65:5-29.
  4. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 1985;56:403-12.
  5. Edmondson RJ, Crosbie EJ, Nickkho-Amiry M, et al. Markers of the p53 pathway further refine molecular profiling in highrisk endometrial cancer: A transportec initiative. Gynecol Oncol 2017;146:327-33.
  6. Santaballa A, Matías-Guiu X, Redondo A, et al. SEOM clinical guidelines for endometrial cancer. Clin Transl Oncol 2018;20(1):29-37.
  7. Mariani A, Webb MJ, Keeney GL, et al. Low-risk corpus cancer: Is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000;182:1506-19.
  8. Schink JC, Miller DS, Lurain JR, et al. Tumor size in endometrial cancer. Cancer 1991;67:2791-4.
  9. Vargas R, Rauh-Hain JA, Clemmer J, et al. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: A SEER analysis. Gynecol Oncol 2014;133(2):216-20.
  10. Zaino RJ, Kurman RJ, Diana KL, et al. Pathologic models to predict outcome for women with endometrial adenocarcinoma: The importance of the distinction between surgical stage and clinical stage--a gynecologic oncology group study. Cancer 1996;77(6):1115-21.
  11. Dos Reis R, Burzawa JK, Tsunoda AT, et al. Lymphovascular space ınvasion portends poor prognosis in low-risk endometrial cancer. Int J Gynecol Cancer 2015;25(7):1292- 9. O'Brien DJ, Flannelly G, Mooney EE, et al. Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with